← Back to companies
ALX Oncology
Biopharmaceuticals1 open
64+ employees
ALX Oncology (Nasdaq: ALXO) is a clinical-stage biotechnology company advancing therapies that boost the immune system to treat cancer and extend patients’ lives. ALX Oncology’s lead therapeutic candidate, evorpacept, has demonstrated potential to serve as a cornerstone therapy upon which the future of immuno-oncology can be built. Evorpacept is currently being evaluated across multiple ongoing clinical trials in a wide range of cancer indications.
Open Positions at ALX Oncology (1 Jobs)
Ready to start your space career at ALX Oncology?
